Taryn Boivin
Geen lopende functies
Profiel
Taryn Boivin held several positions in the pharmaceutical and biotech industry, including Business Manager-Life Sciences at Agilent Technologies, VP-Pharmaceutical Sciences & Manufacturing at Correvio Pharma Corp., Vice President-Pharmaceutical Development at OncoGenex Technologies, and Senior VP-Scientific Affairs & Operations at viDA Therapeutics.
She was also a member of the Glaxo Canada Pharmaceutical Development Organization.
Boivin earned a doctorate degree from the University of Alberta and an undergraduate degree from Simon Fraser University.
Eerdere bekende functies van Taryn Boivin
| Bedrijven | Functie | Einde |
|---|---|---|
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Operationeel Directeur | - |
OncoGenex Technologies, Inc.
 OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
| Glaxo Canada Pharmaceutical Development Organization | Corporate Officer/Principal | - |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
| CORREVIO PHARMA CORP. | Corporate Officer/Principal | - |
Opleiding van Taryn Boivin
| University of Alberta | Doctorate Degree |
| Simon Fraser University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Commercial Services |
| Bedrijven in privébezit | 4 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Technology |
viDA Therapeutics, Inc.
viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Health Technology |
| Glaxo Canada Pharmaceutical Development Organization |
